[1]
S. GOKHALE, S. RAY, V. K. CHOPRA, U. JADHAV, and G. BILLA, “Cost-Consequence Analysis of Sacubitril/Valsartan versus Enalapril in Chronic Heart Failure Patients with Reduced Ejection Fraction”, AMI, vol. 43, no. 2, pp. 81-90, Jul. 2021.